About Us

Enterprise Profile

hubei hongyuan pharmaceutical technology co., ltd (securities referred to as: hongyuan pharmaceutical, securities code: 301246) is located in the southern foot of the dabie mountain luotian county. Founded in 2002, the company has a registered capital of 0.4 billion yuan and total assets of 6 billion yuan. It has 6 wholly-owned subsidiaries and 3 shareholding companies. The company is a "high-tech enterprise" and has successively won the honorary titles of "China quality AAAA credit enterprise", "top 100 comprehensive strength of industrial enterprises in China's chemical and pharmaceutical industry", "top 100 Chinese pharmaceutical enterprises", "key leading enterprise of agricultural industrialization in Hubei Province", "top 100 manufacturing enterprises of private enterprises in Hubei Province" and "top ten production and high-quality API product brands in Hubei pharmaceutical industry.

The company has established a relatively complete pharmaceutical industry chain, and has realized the complete product route coverage of nitroimidazole antibacterial drugs and anti-herpes virus drugs from starting materials, key intermediates to bulk drugs, and preparations. It has become the global nitroimidazole antibacterial One of the main suppliers of raw materials and intermediates, anti-herpes virus raw materials and intermediates, and penicillin antibacterial intermediates, the core product market share of the industry first.

In addition, the company produces lithium hexafluorophosphate, the key material for lithium battery electrolyte. It is one of the domestic early industrialized mass production of lithium hexafluorophosphate and has become one of the main suppliers of BYD and other industries.

The company is a high-tech enterprise, an innovative enterprise in Hubei Province, and an intellectual property advantage enterprise in Hubei Province (patent category). It maintains close exchanges and good cooperation with well-known universities such as Fudan University, Wuhan University, Sichuan University, Wuhan Engineering University, Hubei University of Traditional Chinese Medicine, etc. R & D relationship, established provincial enterprise technology center, Hubei fluorine chemical engineering technology research center, Wuhan R & D center, formed a relatively complete technological innovation system, there are a number of independent intellectual property rights in raw materials and pharmaceutical intermediates, pharmaceutical preparations, new energy materials, etc., with 65 patents, including 57 invention patents, and innovative processes have won provincial scientific and technological progress awards for many times. The company has obtained 47 drug approval numbers, 7 API record numbers and 2 veterinary drug product approval numbers.

The company adheres to the business philosophy of "social integrity-based, customer satisfaction is proud", practices the core values of "people-oriented, unity, dedication, innovation, development, and win-win", and carries "creating value for customers and creating happiness for employees. The great mission of sharing responsibilities for the society and serving a better life, in order to build a" hundred years Hongyuan, green Hongyuan, civilization Hongyuan, happiness Hongyuan "corporate vision and strive.